This inventor holds 1 USPTO granted patent. Top assignee: Xintela Ab. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Folke Sjöberg: Innovator in Stem Cell Therapy
Introduction
Folke Sjöberg is a notable inventor based in Linköping, Sweden. He has made significant contributions to the field of regenerative medicine, particularly in the treatment of skin defects. His innovative work focuses on the use of mesenchymal stem cells (MSCs) to enhance healing processes.
Latest Patents
Sjöberg holds a patent for "Mesenchymal stem cells for use in the treatment of skin defects." This invention relates to therapeutics and methods for treating skin defects using compositions comprising integrin α10-selected MSCs. The patent outlines how these MSC populations and specific culture conditions can improve cell viability, paracrine activity, and regenerative function when applied to damaged skin tissue. The compositions developed promote wound healing, modulate inflammatory responses, and support re-epithelialization. Additionally, the patent provides dosing parameters and administration routes that are suitable for improving healing outcomes in both acute and chronic skin defects. He has 1 patent to his name.
Career Highlights
Sjöberg is associated with Xintela AB, a company that focuses on developing stem cell therapies. His work at Xintela has been pivotal in advancing the application of MSCs in clinical settings. His research has the potential to revolutionize how skin defects are treated, offering new hope for patients with challenging wounds.
Collaborations
Some of his notable coworkers include Evy Lundgren Åkerlund and Hooi Ching Lim. Their collaborative efforts contribute to the innovative research environment at Xintela AB.
Conclusion
Folke Sjöberg's contributions to the field of regenerative medicine through his patent on mesenchymal stem cells highlight his role as an innovator in the treatment of skin defects. His work continues to pave the way for advancements in therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile